BR100 Decreased By (-0.55%)
BR30 Decreased By (-0.86%)
KSE100 Decreased By (-0.47%)
KSE30 Decreased By (-0.6%)
AGHA 6.05 Decreased By ▼ -0.05 (-0.82%)
BECO 3.83 Decreased By ▼ -0.05 (-1.29%)
BML 58.33 Decreased By ▼ -1.66 (-2.77%)
BOP 28.35 Decreased By ▼ -0.31 (-1.08%)
CNERGY 13.64 Decreased By ▼ -0.44 (-3.13%)
CSIL 5.21 Increased By ▲ 0.02 (0.39%)
FCCL 52.28 Decreased By ▼ -0.33 (-0.63%)
FFL 12.90 Decreased By ▼ -0.09 (-0.69%)
FNEL 1.13 Increased By ▲ 0.01 (0.89%)
KEL 5.79 Decreased By ▼ -0.17 (-2.85%)
KOSM 5.51 Increased By ▲ 0.22 (4.16%)
LOTCHEM 23.89 Decreased By ▼ -0.58 (-2.37%)
MLCF 90.51 Decreased By ▼ -0.52 (-0.57%)
NBP 159.72 Decreased By ▼ -2.38 (-1.47%)
NCPL 49.60 Increased By ▲ 0.59 (1.2%)
NPL 51.80 Decreased By ▼ -0.61 (-1.16%)
OGDC 306.78 Increased By ▲ 0.57 (0.19%)
PACE 9.15 Decreased By ▼ -0.10 (-1.08%)
PAEL 32.33 Decreased By ▼ -0.39 (-1.19%)
PIBTL 12.93 Decreased By ▼ -0.15 (-1.15%)
PPL 213.93 Decreased By ▼ -1.59 (-0.74%)
PRL 96.96 Decreased By ▼ -3.85 (-3.82%)
PTC 45.19 Decreased By ▼ -0.83 (-1.8%)
SSGC 22.53 Decreased By ▼ -0.61 (-2.64%)
TBL 9.02 Decreased By ▼ -0.12 (-1.31%)
TELE 6.72 Decreased By ▼ -0.09 (-1.32%)
TPL 25.91 Increased By ▲ 1.15 (4.64%)
TPLP 12.60 Increased By ▲ 0.31 (2.52%)
TREET 23.46 Decreased By ▼ -0.52 (-2.17%)
TRG 51.96 Decreased By ▼ -1.12 (-2.11%)
By

GENEVA: A “huge number” of poorer countries have had to suspend their coronavirus vaccination programmes due to a lack of doses, the World Health Organization said Friday.

The shortages often mean people who have received one dose of Covid-19 vaccine have to wait too long before they can get their second jab.

“We have a huge number of countries that have had to suspend their rollout of their second doses of vaccine,” said Bruce Aylward, the WHO’s frontman for the international Covax scheme which provides vaccine doses to poorer countries.

“If I remember correctly, it’s over 30 or 40 countries that could have been targeted for second doses of AstraZeneca vaccines, for example, who will not be able to do that,” Aylward added.

The countries affected by this problem are spread throughout the Indian subcontinent, sub-Saharan Africa, Latin America and the Middle East, the WHO expert said.

Countries around India, like Nepal and Sri Lanka, have been “particularly hit hard” and face “a severe wave of disease”, he added.

The Serum Institute of India (SII), producing AstraZeneca doses, was supposed to be the backbone of Covax’s supply chain — but India restricted exports to combat its own devastating coronavirus surge.

Comments

Comments are closed for this article.